QL
BMRN icon

Quarry LP’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quarry LP’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Buy
17,624
+7,624
+76% +$418K 0.08% 90
2026
Q1 		$565K Hold
10,000
– – 0.1% 140
2025
Q4 		$594K Buy
+10,000
New +$544K 0.09% 120
2025
Q3 		– Sell
-2,700
Closed -$148K – 2194
2025
Q2 		$148K Buy
+2,700
New +$159K 0.03% 422
2024
Q4 		– Sell
-2,500
Closed -$176K – 1647
2024
Q3 		$176K Buy
2,500
+2,372
+1,853% +$198K 0.04% 268
2024
Q2 		$10.5K Buy
+128
New +$10.7K ﹤0.01% 1310

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Quarry LP's BMRN Position: Q2 2026 in Review

Quarry LP increased its BioMarin Pharmaceuticals (BMRN) stake by 76% in Q2 2026, buying an estimated $418K and bringing the position to 17,624 shares worth $1.01M. The position accounts for 0.08% of the portfolio, ranked #90.

Quarry LP first reported a position in BMRN in Q2 2024 and has held it in 6 quarters since. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Quarry LP held 17,624 shares of BioMarin Pharmaceuticals worth $1.01M as of Q2 2026.
  • Quarry LP bought 7,624 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $418K.
  • BioMarin Pharmaceuticals made up 0.08% of Quarry LP's portfolio in Q2 2026, its #90 holding.
  • Quarry LP first reported a position in BioMarin Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.